Abiopharma

Clinical trial NCT07377526: status: RECRUITING → SUSPENDED.

Clinical trial NCT05304767 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-03-19 → 2026-03-25 3. primary completion date: 2026-03-19 → 2026-03-25 4. enrollment: 280 → 290 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06200207: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07220824: completion date: 2027-09-30 → 2028-06-30.

Clinical trial NCT07030517 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06425302 updates: 1. primary completion date: 2026-11-23 → 2026-06-19 2. enrollment: 90 → 95 participants 3. enrollment type: ESTIMATED → ACTUAL

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-07-31 <b>AccNo:</b> 0001839882-26-037504 <b>Size:</b> 459 KB

Clinical trial NCT06708897 updates: 1. completion date: 2028-04-01 → 2028-07-01 2. primary completion date: 2026-03-01 → 2028-01-01 3. enrollment: 66 → 84 participants 4. allocation: NON_RANDOMIZED → RANDOMIZED

Clinical trial NCT06878404: primary completion date: 2026-07-24 → 2026-05-25.

Clinical trial NCT07716098 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-03 → 2026-07-27

Clinical trial NCT07539844 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-07-02

Clinical trial NCT07136077 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 20 → 15 participants 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NON_RANDOMIZED → NA

Clinical trial NCT07589634 updates: 1. start date: 2026-07-20 → 2026-06-30 2. completion date: 2030-11-08 → 2030-12-02

Clinical trial NCT06347159 updates: 1. completion date: 2026-12-01 → 2027-12-01 2. primary completion date: 2026-06-01 → 2027-12-01 3. enrollment: 100 → 79 participants

Clinical trial NCT03386539 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-01-01 → 2023-05-17